Back
Greek Organisation of Football Prognostics SA Vs. Avidity Biosciences Industry Stock Comparison
Buy
78
GOFPY
Greek Organisation of Football Prognostics SA
Last Price:
$11.49
Seasonality Move:
-0.68%
Sell
47
RNA
Avidity Biosciences
Last Price:
$31.48
Seasonality Move:
-6.84%
Buy
78
Greek Organisation of Football Prognostics SA (GOFPY)
is a Buy
Is Greek Organisation of Football Prognostics SA a Buy, Sell or Hold?
-
The current Greek Organisation of Football Prognostics SA [GOFPY] share price is $11.57. The Score for GOFPY is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
GOFPY is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
-
The current Avidity Biosciences [RNA] share price is $31.47. The Score for RNA is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
RNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GOFPY Stock Price Chart
What is Greek Organisation of Football Prognostics SA's stock price today?
-
The Greek Organisation of Football Prognostics SA share price today is $11.57Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GOFPY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $31.47Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
GOFPY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.16 | Buy |
Relative Strength Index (14 RSI): | 56.02 | Buy |
Chaikin Money Flow: | 6584 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (10.9 - 11.52) | Buy |
Bollinger Bands (100): | (9.54 - 11.42) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.8 | Buy |
Relative Strength Index (14 RSI): | 56.88 | Buy |
Chaikin Money Flow: | 749484 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.61 - 32.95) | Buy |
Bollinger Bands (100): | (27.86 - 32.56) | Buy |
GOFPY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.54 | Buy |
20-day SMA: | 11.28 | Buy |
50-day SMA: | 11.24 | Buy |
200-day SMA: | 9.44 | Buy |
8-day EMA: | 6.07 | Buy |
20-day EMA: | 2.97 | Buy |
50-day EMA: | 1.3 | Buy |
200-day EMA: | 0.34 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.52 | Buy |
20-day SMA: | 29.86 | Buy |
50-day SMA: | 30.66 | Buy |
200-day SMA: | 34.66 | Sell |
8-day EMA: | 16.33 | Buy |
20-day EMA: | 7.97 | Buy |
50-day EMA: | 3.47 | Buy |
200-day EMA: | 0.91 | Buy |
Greek Organisation of Football Prognostics SA Earnings Growth & GOFPY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.15 per share, a decrease this year of $1.09 per share, and a decrease next year of $0.45 per share.
Greek Organisation of Football Prognostics SA Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |